Research Topics
| C J MulderSummaryAffiliation: Rijnstate Hospital Country: The Netherlands Publications
|
Detail Information
Publications
A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicentre tC J J Mulder
Department of Gastroenterology, Rijnstate Ziekenhuis, Arnhem, The Netherlands
Eur J Gastroenterol Hepatol 14:649-56. 2002..Until now, no study had compared the PPIs omeprazole Multiple Unit Pellet System (MUPS), lansoprazole and pantoprazole in patients with reflux oesophagitis...
[Intraluminal therapy for Zenker's diverticulum]C J Mulder
Department of Hepatogastroenterology, Rijnstate Hospital, Arnheim
Chirurg 70:757-60. 1999..All these treatments seem effective. Comparative trials between these approaches are now long overdue, since all these modalities will work in the hands of experienced "Zenker specialists"...
A pilot study of recombinant human interleukin-10 in adults with refractory coeliac diseaseC J Mulder
Department of Gastroenterology, Rijnstate Hospital, Arnhem, The Netherlands
Eur J Gastroenterol Hepatol 13:1183-8. 2001..Two dropped out because of side effects and in only one patient did we see a normalization of villous architecture...
Zapping Zenker's diverticulum: gastroscopic treatmentC J Mulder
Department of Hepatogastroenterology, Rijnstate Hospital, Arnhem, The Netherlands
Can J Gastroenterol 13:405-7. 1999..The mean number of treatment sessions was 1.8. This approach seems safe and effective. Treatment of every patient was possible and was carried out, even in patients in very poor condition, without general anesthesia...
No additional value of bismuth subcitrate to combination omeprazole/amoxicillin therapy in the eradication of Helicobacter pyloriA C Tan
Department of Hepato Gastroenterology, Rijnstate Hospital, Arnhem, The Netherlands
Helicobacter 2:194-8. 1997..We investigated whether addition of bismuth subcitrate (BSC, 4 x 120 mg) to a two week therapy scheme of omeprazole (OME, 2 x 40 mg)/amoxicillin (AMO, 4 x 500 mg) increases Helicobacter pylori eradication...
Cyclosporin in the treatment of adults with refractory coeliac disease--an open pilot studyP J Wahab
Department of Gastroenterology and Hepatology, University Hospital Nijmegen
Aliment Pharmacol Ther 14:767-74. 2000..To evaluate the effect of cyclosporin treatment on clinical and histological parameters in adult patients with refractory coeliac disease...
Indigo carmine chromoendoscopic appearances of enteropathy-associated T-cell lymphoma during double-balloon endoscopy in a patient with celiac diseaseM Hadithi
Small Bowel Diseases Unit, Department of Gastroenterology, VU University Medical Center, Amsterdam, The Netherlands
Endoscopy 39:E212-3. 2007
Coeliac disease. Three cases of delayed diagnosis after a sojourn in the tropicsJ D van Bergeijk
Department of Gastroenterology, Rijnstate Hospital, Arnhem, Netherlands
Neth J Med 43:222-6. 1993..Three patients are described in whom the diagnosis of coeliac disease was missed because of a recent sojourn in the tropics. The differences between coeliac disease and tropical sprue, as well as the diagnostic pathways, are discussed...
The relationship between anti-endomysium antibodies and villous atrophy in coeliac disease using both monkey and human substrateK Rostami
Hepatogastroenterology Pathology Immunology Rijnstate Hospital, Arnhem, The Netherlands
Eur J Gastroenterol Hepatol 11:439-42. 1999..This study assesses for the first time the sensitivity and reliability of anti-endomysium in screening for coeliac disease in patients with milder forms of villous atrophy using human umbilical cord and monkey ileum...
Drug therapy: dose-response relationship of oral mesalazine in inflammatory bowel diseaseC J Mulder
Department of Gastroenterology, Rijnstate Hospital, Arnhem, The Netherlands
Mediators Inflamm 7:135-6. 1998..In conclusion, despite the current practice of using increasing dosages of mesalazine in inflammatory bowel disease, both efficacy and safety have been established tentatively...
